FILTER

FILTERED INTERVIEW RESULTS

Mining
Namibia
MACIG

Jed Richardson

PRESIDENT & CEO, TRIGON METALS
Trigon Metals is set to produce copper at its Kombat mine and intends to use the cash flow for continued exploration in Morocco and Namibia.
Mining
South Africa
MACIG

Eric Bruggeman

CEO, SOUTH AFRICA CAPITAL EQUIPMENT EXPORT COUNCIL (SACEEC)
South Africa Capital Equipment Council (SADEEC) explains how South African equipment and machinery for mining is popular around the world.
Mining
DRC
MACIG

Oscar Siviwe

GENERAL MANAGER, TOP ENGINEERING SERVICES
Top Engineering Services offers local steel fabrication and engineering services for mines in DRC.
Mining
Australia
DRC
MACIG

Nigel Ferguson

MANAGING DIRECTOR, AVZ MINERALS
MACIG Copperbelt & Angola 2021
AVZ Minerals talks about setting up its Manono lithium and tin project in DRC.
Mining
Ghana
MACIG

Regina Ofori-Twumasi

MANAGING CONSULTANT, ALFREG
Alfreg explains how it can help mining companies to establish in Ghana.
Mining
DRC
MACIG

Feni Matsando Samuel

CEO, INTER-ORIENTAL BUILDERS (IOB)
MACIG Copperbelt & Angola 2021
IOB is a Congolese contractor that looks to develop national skills with the mining industry
Mining
South Africa
Zambia
DRC
Mozambique
Namibia
Niger
Nigeria
Angola
MACIG

Shahram Tafazoli

FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Mining
Mali
MACIG

Alistair Cowden

EXECUTIVE CHAIRMAN, FIREFINCH
Firefinch is a West Australian goal company redeveloping the former Morila gold mine in Mali.
Mining
DRC
MACIG

Djo Moupondo

CEO, SODEICO
Sodeico explains how it can meet the challenges of providing a skilled workforce for mines in DRC.
Mining
Ghana
MACIG

Zoe Phillips Takyi - Appiah

SENIOR PARTNER, JLD AND MB LEGAL CONSULTANCY
JLD and MB Legal Consultancy comment on the current investment climate in Ghana’s extractive industries.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL